[1]
“BETWEEN EFFICACY AND RISK: A CRITICAL APPRAISAL OF METAMIZOLE’S PHARMACOLOGY, CLINICAL USE AND REGULATORY STATUS”, IJITSS, vol. 5, no. 3(47), Sep. 2025, doi: 10.31435/ijitss.3(47).2025.3753.